Faster global financial news!
XRPL
-
Aviva Investors launches tokenized fund after Central Bank of Ireland approval
Aviva Investors has launched a tokenized fund, following approval from the Central Bank of Ireland. The new XRPL-based share class provides eligible investors with blockchain-based access to a regulat
-
Ripple plans to introduce an institutional-grade lending protocol on the XRPL, allowing users to obtain financing using tokenized assets as collateral
Svmuu News: Ripple is promoting the addition of a new layer of lending infrastructure on the XRP Ledger (XRPL), enabling institutions to secure financing using on-chain tokenized assets as collateral,
-
Ripple Launches XRPL Agentic Payment Toolkit, Positioning for AI-Automated Payment Infrastructure
Svmuu reported that Ripple has announced a new toolkit for developers to build "agentic payments" applications on the XRP Ledger (XRPL), enabling AI agents to execute automated financial transactions.
-
Aviva Investors launches tokenized fund after Central Bank of Ireland approval
Aviva Investors has launched a tokenized fund, following approval from the Central Bank of Ireland. The new XRPL-based share class provides eligible investors with blockchain-based access to a regulat
-
Ripple plans to introduce an institutional-grade lending protocol on the XRPL, allowing users to obtain financing using tokenized assets as collateral
Svmuu News: Ripple is promoting the addition of a new layer of lending infrastructure on the XRP Ledger (XRPL), enabling institutions to secure financing using on-chain tokenized assets as collateral,
-
Ripple Launches XRPL Agentic Payment Toolkit, Positioning for AI-Automated Payment Infrastructure
Svmuu reported that Ripple has announced a new toolkit for developers to build "agentic payments" applications on the XRP Ledger (XRPL), enabling AI agents to execute automated financial transactions.
- No data
XRPL
24H Trending
-
1
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
2
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
3
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
4
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
5
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
-
6
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
7
TRIVIA Coin: Originally Designed to Create a Blockchain-Based Trivia Game—Analysis of Current Market Performance and Project Status
-
8
Berkshire Hathaway Holds Record $400B Cash, Net Seller for 3+ Years; "Buffett Indicator" Hits All-Time High Suggesting Stocks Are Expensive
-
9
What Is POLA? Background and Investment Risk Analysis of the Pola On Base Project
-
10
Claiming Social Security benefits at age 62 instead of 67 can reduce monthly payments by 30%, potentially costing average retirees $150,000 over 20 years.
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
